Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will p...
Enregistré dans:
| Hovedforfatter: | |
|---|---|
| Andre forfattere: | |
| Format: | Livre numérique |
| Sprog: | Anglais |
| Udgivet: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer
[20..].
Cham : Springer Nature |
| Online adgang: | Accès sur la plateforme de l'éditeur Accès sur la plateforme Istex Accès Université d'Orléans Accès INSA CVL |
| Kommentar: |
Archives Springer e-books (Licence nationale) Archives Springer e-books (Licence nationale) |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics, Texte imprimé, 9783642407161 |
Indholdsfortegnelse:
- Brief historical account of HBOC development Physiology of respiration Oxygen transport to tissues Pathophysiology of acute anemia Global blood safety and need for safe blood supply Blood transfusion and its limitations Scientific basis and design of HBOCs HBOCs: a regulatory perspective Current HBOC products in development Clinical indications and clinical trials of HBOCs HBOCs and adverse events observed in clinical trials HBOC-mediated vasoactivity and hypertension HBOC and oxygen and nitrogen radical mediated toxicity HBOCs and clinical laboratory interference Animal models for HBOC studies New emerging Technologies for universal RBCs Future prospects